Elastography Imaging Market Size, Share & Trends Analysis Report By Modality (Magnetic Resonance, Ultrasound), By Application (General Imaging, Hepatology, Cardiology, Breast), By End Use (Hospitals, Imaging Centers), and Segment Forecasts, 2025 - 2030

Elastography Imaging Market Size & Trends

The global elastography imaging market size was estimated at USD 2.28 billion in 2024 and is projected to grow at a CAGR of 7.32% over the forecast period 2025 to 2030. The increasing prevalence of chronic liver and breast cancer, coupled with a growing demand for advanced diagnostic techniques, stands as significant drivers for the elastography imaging industry. In addition, a strong preference for minimally or non-invasive surgical procedures is anticipated to further propel market growth throughout the forecast period.

The elastography technique is garnering increased popularity and acceptance among both patients and physicians, primarily owing to its non-invasive characteristics and precise assessment of tissue mechanical properties. Advanced elastography systems not only offer detailed quantitative but also qualitative diagnostic capabilities. The rising demand for sophisticated diagnostic techniques in developing nations is anticipated to displace traditional ultrasound methods with elastography, significantly boosting the elastography imaging industry.

Shear wave elastography provides a large number of advantages over other diagnostic techniques. The technique helps reduce the need for biopsy in various breast conditions. It is widely used to assess liver conditions before and after transplantation and monitor the degree of liver cirrhosis. Increasing incidence of breast and liver conditions is expected to boost demand for elastography systems.

Elastography has potential applications in early detection of tumors. It can be used effectively to accurately detect tiny nodules in glands. This is expected to increase the adoption of elastography in preventive healthcare. Further, an increasing number of ongoing studies to assess potential applications of elastography is expected to fuel the market during the forecast period. A large number of these studies include ophthalmic applications such as analysis of oculomotor muscles and assessment of mechanical properties of cornea.

Market Concentration & Characteristics

The elastography imaging industry is accelerating at a significant rate, driven by advancements in imaging technology, increasing prevalence of chronic liver diseases, and a growing demand for non-invasive diagnostic tools. The rising incidence of conditions such as liver fibrosis, cancer, and musculoskeletal disorders has fueled the need for precise and early-stage detection methods, positioning elastography as a preferred alternative to traditional biopsy procedures. Technological innovations, including the integration of artificial intelligence (AI) and machine learning, have further enhanced the accuracy and efficiency of elastography techniques, making them more accessible across various clinical settings.

In addition, supportive government initiatives and increased healthcare expenditure have played a crucial role in expanding the adoption of elastography, particularly in emerging markets where the focus on early disease diagnosis is gaining momentum. As a result, the industry continues to experience robust growth, with major players investing in research and development to refine elastography systems and broaden their clinical applications.

The elastography imaging industry experienced notable innovations including advancements in strain and shear wave techniques, integration with various modalities, enhanced clinical applications, and the incorporation of machine learning for improved analysis.

Several market players such as Canon Medical Systems Corporation, GE Healthcare, and Koninklijke Philips N.V, are involved in merger and acquisition activities. Through M&A activity, these companies can expand their geographic reach and enter new territories.

Regulatory measures have influenced the elastography imaging industry by shaping standards for quality and safety, fostering market growth through increased confidence in the technology, while compliance challenges and approval processes may impact the speed of industry entry for new innovations.

Manufacturers are actively launching new products to expand their offerings, driven by the increasing demand for advanced elastography solutions in healthcare. Companies are investing heavily in research and development to introduce innovative technologies that enhance imaging accuracy, improve ease of use, and expand clinical applications beyond traditional liver disease assessment.

Regional expansion driven by increasing healthcare infrastructure investments, growing awareness of non-invasive diagnostic methods, and the adoption of advanced imaging technologies, particularly in emerging economies.

Modality Insights

The ultrasound segment held the largest share of over 69.40% in 2024 owing to benefits such as affordability, short turnaround time, and easy availability. Ultrasound elastography is gradually replacing conventional ultrasound devices used for organ assessment and biopsy procedures.

The MRI segment is expected to show lucrative growth during the forecast period. The utilization of magnetic resonance imaging (MRI) is gaining prominence as the preferred method for diagnosing liver diseases. The increasing adoption of MRE can be attributed to its precise results and the painless nature of the procedure, which collectively contribute to the growth of this segment. MRE proves to be an effective tool for diagnosing advanced liver fibrosis, aiding in gauging the severity of liver disease and assisting in determining the appropriate course of treatment.

Application Insights

The general imaging segment accounted for the largest revenue share of 32.5% in 2024 due to its widespread utility across various medical disciplines. Elastography, as a non-invasive technique for assessing tissue stiffness, finds extensive use in general imaging applications, including liver disease diagnosis, cancer detection, and musculoskeletal assessments. Its versatility allows healthcare professionals to obtain valuable information in routine clinical settings, contributing to its dominance as a go-to diagnostic tool.

The breast segment is estimated to register the fastest CAGR of 8.40% over the forecast period due to the increasing demand for non-invasive and accurate diagnostic tools in breast health assessment. Elastography imaging offers a valuable adjunct to traditional breast imaging methods by providing insights into tissue stiffness, aiding in the early detection and characterization of breast lesions.

End Use Insights

The hospital segment dominated the market in 2024 by capturing a share of 39.81% owing to the rising adoption of ultrasound and MRI-based elastography procedures. Hospitals serve as key healthcare providers equipped with advanced imaging infrastructure, enabling them to perform a high volume of elastography-based diagnostic and therapeutic procedures. The increasing prevalence of chronic liver diseases, musculoskeletal disorders, and cardiovascular conditions has further fueled the demand for elastography in hospital settings.

The imaging centers segment has been anticipated to show lucrative growth of CAGR 7.71% over the forecast period. Increasing adoption of non-invasive surgical and diagnostic procedures in these facilities by professionals is expected to drive the segment during the forecasted period. In addition, growing adoption of automation among surgeons and other specialists is anticipated to augment demand for these systems in different hospital settings.

Regional Insights

North America elastography imaging market held the largest share of 33.2% in 2024, driven by the presence of a large number of global players in the region. Moreover, increasing efforts by manufacturers for commercialization and growing importance among end users for the use of these systems in different countries is driving the regional market.

U.S. Elastography Imaging Market Trends

The U.S. elastography imaging market accounted for the largest share in North American region in 2024. The U.S. benefits from a robust ecosystem of healthcare institutions, key market players, and research facilities, facilitating the rapid integration of elastography imaging into clinical practices. In addition, a favorable reimbursement landscape and a proactive approach to early disease detection contribute to the widespread acceptance in various medical applications, further solidifying the U.S.'s leading position in the North American region.

Europe Elastography Imaging Market Trends

The Europe elastography imaging market is expected to grow owing to the increasing awareness of non-invasive diagnostic techniques, advancements in imaging technology, and a rising prevalence of chronic diseases such as liver fibrosis, cancer, and musculoskeletal disorders. The region's well-established healthcare infrastructure, coupled with strong government support for early disease detection and preventive healthcare, has facilitated the widespread adoption of elastography.

The UK elastography imaging market is expected to grow over the forecast period, driven by increasing adoption of advanced diagnostic imaging technologies and a strong emphasis on early disease detection. The rising prevalence of liver disorders, particularly due to alcohol-related liver disease and non-alcoholic fatty liver disease (NAFLD), has heightened the demand for non-invasive assessment tools like elastography. In addition, the National Health Service (NHS) and private healthcare providers are investing in cutting-edge imaging solutions to enhance patient outcomes and reduce the need for invasive biopsies

The Germany imaging elastography market is driven by the country’s advanced healthcare infrastructure, strong research and development ecosystem, and increasing prevalence of chronic diseases such as liver fibrosis and cancer. With a high adoption rate of innovative medical imaging technologies, German hospitals and diagnostic centers are increasingly incorporating elastography into routine clinical practice. In addition, the country’s emphasis on early disease detection and preventive healthcare, supported by government initiatives and favorable reimbursement policies, is further accelerating market expansion.

Asia Pacific Elastography Imaging Market Trends

The Asia Pacific elastography imaging market is expected to grow at the fastest rate during the forecast period. Increasing geriatric population, improving healthcare services, and rapid economic growth are factors expected to drive the regional market. Growth in Asia Pacific is majorly contributed by economies such as India, Japan, and China due to speedy expansion of healthcare facilities. Furthermore, increasing awareness among the public concerning therapeutic potential of ultrasound technologies and accurate and speedy results provided by these devices is contributing to the regional market.

China elastography imaging market accounted for the largest share t in the Asia Pacific region in 2024. The country's large population and rising healthcare awareness drive the demand for advanced diagnostic tools, including elastography imaging, for conditions such as liver disease and cancer. Moreover, the Chinese government's initiatives to modernize healthcare and promote research and development contribute to the widespread adoption of innovative medical imaging technologies.

The Japan elastography imaging market is expected to witness significant growth, driven by the country’s rapidly aging population, increasing prevalence of chronic liver diseases, and strong focus on technological innovation in medical imaging. Japan’s well-established healthcare infrastructure and high adoption rate of advanced diagnostic tools have facilitated the integration of elastography into routine medical practice, particularly in hepatology, oncology, and musculoskeletal imaging.

Latin America Elastography Imaging Market Trends

The Latin America elastography imaging market is experiencing steady growth, driven by increasing awareness of non-invasive diagnostic techniques, rising prevalence of liver diseases, and improving healthcare infrastructure across the region. Countries such as Brazil, and Argentina are witnessing a higher adoption of elastography, particularly in hepatology and oncology. In addition, government efforts to enhance early disease detection and expand access to advanced medical imaging technologies are further supporting market growth.

MEA Elastography Imaging Market Trends

The MEA elastography imaging market is expected to grow steadily, driven by improving healthcare infrastructure, increasing awareness of non-invasive diagnostic technologies, and a rising burden of chronic diseases such as liver fibrosis and cancer. In the Middle East, countries like the UAE and Saudi Arabia are witnessing greater adoption of elastography due to substantial investments in healthcare modernization and the expansion of advanced diagnostic imaging facilities.

Key Elastography Imaging Company Insights 

Key players in the elastography imaging industry such as Canon Medical Systems Corporation, GE Healthcare, and Koninklijke Philips N.V. are constantly investing in research and development activities to introduce new and advanced products to the market. They are also focusing on strategic partnerships and collaborations to expand their market presence and increase their customer base.

Emerging players such as Esaote SpA and Samsung Medison Co., Ltd are focusing on product innovation and differentiation to gain a competitive edge in the market. They are also expanding their market reach by establishing partnerships and collaborations with other companies in the industry. In addition, these players are adopting various growth strategies, such as offering cost-effective products and solutions, to attract a larger customer base.

Recent Developments

• In June 2023, Nikon Instruments Inc. has revealed the development and release of "ECLIPSE Ui," a comprehensive microscope-based viewing system crafted for seamless clinical observations, catering to both in-person and remote pathological assessments.

• In July 2023, at the Microscopy and Microanalysis (M&M) 2023 Conference, ZEISS Microscopy introduces its latest product launch and highlights new researchers through interactive display features.

• In November 2023, ZEISS introduces new Lattice structured illumination microscopy (SIM) to overcome the physical resolution limits of light microscopy.

Elastography Imaging Market Report Scope

Global Elastography Imaging Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global elastography imaging market report on the basis of modality, application, end use, and region:

• Modality Outlook (Revenue, USD Million, 2018 - 2030)

  • Ultrasound

  • Magnetic Resonance

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • General Imaging

  • Hepatology

  • Breast

  • Cardiology

  • Nephrology

  • Orthopedic and Musculoskeletal

• End Use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals

  • Imaging Centers

  • Others

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • South Korea

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait